{"id":"https://openalex.org/W4392889347","doi":"https://doi.org/10.1016/j.neurol.2024.02.286","title":"Tol\u00e9rance d\u2019ocrelizumab dans la scl\u00e9rose en plaques : analyse actualis\u00e9e chez des patients atteints de scl\u00e9rose en plaques r\u00e9currente (SEP-R) et primaire progressive (SEP-PP)","display_name":"Tol\u00e9rance d\u2019ocrelizumab dans la scl\u00e9rose en plaques : analyse actualis\u00e9e chez des patients atteints de scl\u00e9rose en plaques r\u00e9currente (SEP-R) et primaire progressive (SEP-PP)","publication_year":2024,"publication_date":"2024-03-16","ids":{"openalex":"https://openalex.org/W4392889347","doi":"https://doi.org/10.1016/j.neurol.2024.02.286"},"language":"fr","primary_location":{"id":"doi:10.1016/j.neurol.2024.02.286","doi":"https://doi.org/10.1016/j.neurol.2024.02.286","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neurol.2024.02.286","pdf_url":null,"source":{"id":"https://openalex.org/S124451323","display_name":"Revue Neurologique","issn_l":"0035-3787","issn":["0035-3787","2213-0004"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue Neurologique","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071976849","display_name":"Cathy Chognot","orcid":"https://orcid.org/0000-0002-3717-5168","observed_orcids":["https://orcid.org/0000-0002-3717-5168"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Cathy Chognot","raw_affiliation_strings":["Safety sciences, F. Hoffmann-La Roche AG, Basel, Suisse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety sciences, F. Hoffmann-La Roche AG, Basel, Suisse","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104805489","display_name":"Stephen L. Hauser","orcid":"https://orcid.org/0000-0002-4932-4001","observed_orcids":["https://orcid.org/0000-0002-4932-4001"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen L. Hauser","raw_affiliation_strings":["UCSF Weill Institute for Neurosciences, university of California San Francisco, San Francisco, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Weill Institute for Neurosciences, university of California San Francisco, San Francisco, \u00c9tats-Unis","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054874316","display_name":"Ludwig Kappos","orcid":"https://orcid.org/0000-0003-4175-5509","observed_orcids":["https://orcid.org/0000-0003-4175-5509"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]},{"id":"https://openalex.org/I2802542264","display_name":"University Hospital of Basel","ror":"https://ror.org/04k51q396","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802542264"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ludwig Kappos","raw_affiliation_strings":["Neurologic clinic and policlinic, departments of medicine, university hospital and university of Basel, B\u00e2le, Suisse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurologic clinic and policlinic, departments of medicine, university hospital and university of Basel, B\u00e2le, Suisse","institution_ids":["https://openalex.org/I1850255","https://openalex.org/I2802542264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031171090","display_name":"Xavier Montalb\u00e1n","orcid":"https://orcid.org/0000-0002-0098-9918","observed_orcids":["https://orcid.org/0000-0002-0098-9918"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Xavier Montalban","raw_affiliation_strings":["Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia, Vall d\u2019Hebron University Hospital, Barcelone, Espagne"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology-Neuroimmunology, Multiple Sclerosis Centre of Catalonia, Vall d\u2019Hebron University Hospital, Barcelone, Espagne","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020629733","display_name":"Elodie Incera","orcid":"https://orcid.org/0009-0002-0719-0807","observed_orcids":["https://orcid.org/0009-0002-0719-0807"]},"institutions":[{"id":"https://openalex.org/I4210144377","display_name":"IQVIA (France)","ror":"https://ror.org/0394bpd20","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210108991","https://openalex.org/I4210144377"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"\u00c9lodie Incera","raw_affiliation_strings":["Statistiques, IQVIA Inc., Paris"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistiques, IQVIA Inc., Paris","institution_ids":["https://openalex.org/I4210144377"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076338840","display_name":"Jerry S. Wolinsky","orcid":"https://orcid.org/0000-0002-8197-2762","observed_orcids":["https://orcid.org/0000-0002-8197-2762"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerry S. Wolinsky","raw_affiliation_strings":["Neurology, University of Texas Health Science Center at Houston: Recreational Center, Houston, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, University of Texas Health Science Center at Houston: Recreational Center, Houston, \u00c9tats-Unis","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3240,"currency":"USD","value_usd":3240},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0482541,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"180","issue":null,"first_page":"S146","last_page":"S146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6869999766349792},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7089999914169312},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.824999988079071},{"id":"https://openalex.org/keywords/infection","display_name":"infection","score":0.828000009059906},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.8669999837875366},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.6520000100135803},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.6690000295639038},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.7350000143051147},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.6389999985694885},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.4180000126361847},{"id":"https://openalex.org/keywords/real-world-registry","display_name":"real-world registry","score":0.6679999828338623},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.421999990940094},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.3330000042915344}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.789418637752533},{"id":"https://openalex.org/C2778335665","wikidata":"https://www.wikidata.org/wiki/Q1155211","display_name":"Rose (mathematics)","level":2,"score":0.47761934995651245},{"id":"https://openalex.org/C2778843634","wikidata":"https://www.wikidata.org/wiki/Q2013780","display_name":"Ocrelizumab","level":4,"score":0.4351175129413605},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19746050238609314},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.neurol.2024.02.286","doi":"https://doi.org/10.1016/j.neurol.2024.02.286","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.neurol.2024.02.286","pdf_url":null,"source":{"id":"https://openalex.org/S124451323","display_name":"Revue Neurologique","issn_l":"0035-3787","issn":["0035-3787","2213-0004"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue Neurologique","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3154150226","https://openalex.org/W3083866893","https://openalex.org/W4224035838","https://openalex.org/W3084043993","https://openalex.org/W4224022254","https://openalex.org/W4392889401","https://openalex.org/W3084269814","https://openalex.org/W3156105809","https://openalex.org/W4361027707","https://openalex.org/W2592141746"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2024-03-17T00:00:00"}